Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 65.8MCore Assets
VS
Market
Sector
Industry
History
$ 6.47Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information
Ticker
KPTICompany Name
KARYOPHARM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKARYOPHARM THERAPEUTICS INC - Core Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPTI - Core Assets Historical data
| Date | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
|---|---|---|---|---|
| 6/30/2025 | $ 104.88M | $ 39.08M | $ 65.8M | $ 0 |
| 3/31/2025 | $ 127.71M | $ 39.12M | $ 88.59M | $ 0 |
| 12/31/2024 | $ 164.42M | $ 62.81M | $ 101.6M | $ 0 |
| 9/30/2024 | $ 189.48M | $ 73.17M | $ 116.31M | $ 0 |
| 6/30/2024 | $ 213.98M | $ 85.11M | $ 128.87M | $ 0 |
| 3/31/2024 | $ 204.46M | $ 31.39M | $ 173.07M | $ 0 |
| 12/31/2023 | $ 240.44M | $ 53.19M | $ 187.25M | $ 0 |
| 9/30/2023 | $ 269.96M | $ 44.58M | $ 225.38M | $ 0 |
| 6/30/2023 | $ 297.83M | $ 81.85M | $ 215.98M | $ 0 |
| 3/31/2023 | $ 325.8M | $ 85.54M | $ 240.26M | $ 0 |
Key Performance Insights, Last 5 Years
- KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) Core Assets stands at $ 253.48M.
- Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average Core Assets has been $ 163.09M.
- The median Core Assets for KARYOPHARM THERAPEUTICS INC during this period was $ 165.32M
- KARYOPHARM THERAPEUTICS INC reached its highest Core Assets over the past 5 years at $ 253.48M.
- The lowest Core Assets recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe $ 65.8M
KARYOPHARM THERAPEUTICS INC's Core Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Core Assets Benchmarks
Similar metrics to Intangibles:
- Tangible Assets - [Calculation] A tangible asset is an asset that has physical substance. Typical examples may include [Inventory], equipment or machinery an property. It is calculated by subtracting intangibles & goodwill [Intangibles] from total [Assets].
- Goodwill & Intangibles to Assets Ratio - [Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Goodwill and Intangibles - [Balance Sheet] Goodwill and Intangible Assets are a component of [Assets] representing nonphysical assets like goodwill, patents, trademarks, and copyrights; net of accumulated amortization and impairment charges.
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Core Assets
[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].Assets - Intangibles - CashnEq
(=) Core Assets Core Assets for KARYOPHARM THERAPEUTICS INC is calculated as follows: Assets [ $ 337.59M ] - Intangibles [ $ 0 ] - CashnEq [ $ 84.11M ]
(=) Core Assets [ $ 253.48M ] KPTI - Core Assets, Last 5 years
$ 65.8M
Minimum
Jun 30, 2025
$ 253.48M
Maximum
Sep 30, 2020
$ 163.09M
Average
$ 165.32M
Median
Core Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.62M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | $ 0 |
| max | $ 4.36B |
| average | $ 798.62M |
| median | $ 287.61M |
| std | $ 1.05B |